Where to take cover on D-Street as volatility leaves investors dizzy?

“Markets have not discounted a sharp and long recession in the US. If that scenario pans out, the market may witness sharp drawdowns. Thus, it would be better to partly move into pharma and FMCG,” said Dr V K Vijayakumar, Chief Investment Strategist, Geojit Financial Services. Foreign portfolio investors pumped in Rs 2,765 crore in FMCG stocks in September, the highest inflows last month, while they bought healthcare stocks worth Rs 1,833 crore.